694 related articles for article (PubMed ID: 28725968)
1. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.
Su EJ; Cao C; Fredriksson L; Nilsson I; Stefanitsch C; Stevenson TK; Zhao J; Ragsdale M; Sun YY; Yepes M; Kuan CY; Eriksson U; Strickland DK; Lawrence DA; Zhang L
Acta Neuropathol; 2017 Oct; 134(4):585-604. PubMed ID: 28725968
[TBL] [Abstract][Full Text] [Related]
2. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke.
Su EJ; Fredriksson L; Geyer M; Folestad E; Cale J; Andrae J; Gao Y; Pietras K; Mann K; Yepes M; Strickland DK; Betsholtz C; Eriksson U; Lawrence DA
Nat Med; 2008 Jul; 14(7):731-7. PubMed ID: 18568034
[TBL] [Abstract][Full Text] [Related]
3. Remote ischemic conditioning attenuates blood-brain barrier disruption after recombinant tissue plasminogen activator treatment via reducing PDGF-CC.
He Q; Ma Y; Fang C; Deng Z; Wang F; Qu Y; Yin M; Zhao R; Zhang D; Guo F; Yang Y; Chang J; Guo ZN
Pharmacol Res; 2023 Jan; 187():106641. PubMed ID: 36587812
[TBL] [Abstract][Full Text] [Related]
4. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice.
Wang L; Fan W; Cai P; Fan M; Zhu X; Dai Y; Sun C; Cheng Y; Zheng P; Zhao BQ
Ann Neurol; 2013 Feb; 73(2):189-98. PubMed ID: 23280993
[TBL] [Abstract][Full Text] [Related]
5. Platelet derived growth factor-CC isoform is associated with hemorrhagic transformation in ischemic stroke patients treated with tissue plasminogen activator.
Rodríguez-González R; Blanco M; Rodríguez-Yáñez M; Moldes O; Castillo J; Sobrino T
Atherosclerosis; 2013 Jan; 226(1):165-71. PubMed ID: 23218119
[TBL] [Abstract][Full Text] [Related]
6. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.
Ma Y; Li L; Kong L; Zhu Z; Zhang W; Song J; Chang J; Du G
Biomed Res Int; 2018; 2018():8943210. PubMed ID: 29850586
[TBL] [Abstract][Full Text] [Related]
7. The low-density lipoprotein receptor-related protein 1 mediates tissue-type plasminogen activator-induced microglial activation in the ischemic brain.
Zhang C; An J; Strickland DK; Yepes M
Am J Pathol; 2009 Feb; 174(2):586-94. PubMed ID: 19147818
[TBL] [Abstract][Full Text] [Related]
8. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
[TBL] [Abstract][Full Text] [Related]
9. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment blood-brain barrier damage and post-treatment intracranial hemorrhage in patients receiving intravenous tissue-type plasminogen activator.
Leigh R; Jen SS; Hillis AE; Krakauer JW; Barker PB;
Stroke; 2014 Jul; 45(7):2030-5. PubMed ID: 24876245
[TBL] [Abstract][Full Text] [Related]
12. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
Liu W; Hendren J; Qin XJ; Liu KJ
Stroke; 2009 Jul; 40(7):2526-31. PubMed ID: 19478225
[TBL] [Abstract][Full Text] [Related]
13. Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?
Niego B; Medcalf RL
J Cereb Blood Flow Metab; 2014 Aug; 34(8):1283-96. PubMed ID: 24896566
[TBL] [Abstract][Full Text] [Related]
14. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke.
Lapergue B; Dang BQ; Desilles JP; Ortiz-Munoz G; Delbosc S; Loyau S; Louedec L; Couraud PO; Mazighi M; Michel JB; Meilhac O; Amarenco P
Stroke; 2013 Mar; 44(3):699-707. PubMed ID: 23422087
[TBL] [Abstract][Full Text] [Related]
15. Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway.
Won S; Lee JH; Wali B; Stein DG; Sayeed I
J Cereb Blood Flow Metab; 2014 Jan; 34(1):72-80. PubMed ID: 24045404
[TBL] [Abstract][Full Text] [Related]
16. Tissue-type plasminogen activator is not necessary for platelet-derived growth factor-c activation.
Riehle KJ; Johnson MM; Johansson F; Bauer RL; Hayes BJ; Gilbertson DG; Haran AC; Fausto N; Campbell JS
Biochim Biophys Acta; 2014 Feb; 1842(2):318-25. PubMed ID: 24269585
[TBL] [Abstract][Full Text] [Related]
17. Recombinant tissue-type plasminogen activator transiently enhances blood-brain barrier permeability during cerebral ischemia through vascular endothelial growth factor-mediated endothelial endocytosis in mice.
Suzuki Y; Nagai N; Yamakawa K; Muranaka Y; Hokamura K; Umemura K
J Cereb Blood Flow Metab; 2015 Dec; 35(12):2021-31. PubMed ID: 26219596
[TBL] [Abstract][Full Text] [Related]
18. Canonical Wnt Pathway Maintains Blood-Brain Barrier Integrity upon Ischemic Stroke and Its Activation Ameliorates Tissue Plasminogen Activator Therapy.
Jean LeBlanc N; Menet R; Picard K; Parent G; Tremblay MÈ; ElAli A
Mol Neurobiol; 2019 Sep; 56(9):6521-6538. PubMed ID: 30852795
[TBL] [Abstract][Full Text] [Related]
19. Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain.
Zhang C; An J; Haile WB; Echeverry R; Strickland DK; Yepes M
J Cereb Blood Flow Metab; 2009 Dec; 29(12):1946-54. PubMed ID: 19672275
[TBL] [Abstract][Full Text] [Related]
20. Toll-Like Receptor 4 Mediates Hemorrhagic Transformation After Delayed Tissue Plasminogen Activator Administration in In Situ Thromboembolic Stroke.
García-Culebras A; Palma-Tortosa S; Moraga A; García-Yébenes I; Durán-Laforet V; Cuartero MI; de la Parra J; Barrios-Muñoz AL; Díaz-Guzmán J; Pradillo JM; Moro MA; Lizasoain I
Stroke; 2017 Jun; 48(6):1695-1699. PubMed ID: 28428349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
